UMB Bank N A MO reduced its position in Clorox Co. (NYSE:CLX) by 41.4% during the second quarter, Holdings Channel reports. The fund owned 31,524 shares of the company’s stock after selling 22,286 shares during the period. UMB Bank N A MO’s holdings in Clorox were worth $4,362,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the company. BlackRock Institutional Trust Company N.A. increased its stake in Clorox by 7.5% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 4,504,422 shares of the company’s stock worth $567,827,000 after buying an additional 313,224 shares during the last quarter. BlackRock Group LTD increased its stake in Clorox by 18.2% in the first quarter. BlackRock Group LTD now owns 1,592,689 shares of the company’s stock worth $200,775,000 after buying an additional 245,650 shares during the last quarter. Geode Capital Management LLC increased its stake in Clorox by 2.7% in the first quarter. Geode Capital Management LLC now owns 1,182,810 shares of the company’s stock worth $148,838,000 after buying an additional 30,881 shares during the last quarter. Norges Bank bought a new stake in Clorox during the fourth quarter worth about $98,583,000. Finally, Legal & General Group Plc increased its stake in Clorox by 1.7% in the first quarter. Legal & General Group Plc now owns 682,421 shares of the company’s stock worth $86,041,000 after buying an additional 11,428 shares during the last quarter. Institutional investors own 70.26% of the company’s stock.

Clorox Co. (NYSE:CLX) traded up 1.74% during mid-day trading on Thursday, reaching $126.57. 1,375,237 shares of the company’s stock traded hands. The firm has a market cap of $16.39 billion, a PE ratio of 25.73 and a beta of 0.33. Clorox Co. has a 1-year low of $113.37 and a 1-year high of $140.47. The firm has a 50 day moving average of $129.33 and a 200 day moving average of $130.06.

Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, August 3rd. The company reported $1.26 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.28 by $0.02. The company earned $1.60 billion during the quarter, compared to analyst estimates of $1.58 billion. Clorox had a net margin of 11.25% and a return on equity of 296.91%. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. During the same quarter last year, the company earned $1.44 EPS. Analysts forecast that Clorox Co. will post $5.49 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, November 14th. Stockholders of record on Wednesday, October 26th will be issued a $0.80 dividend. This represents a $3.20 annualized dividend and a dividend yield of 2.53%. The ex-dividend date is Monday, October 24th. Clorox’s dividend payout ratio (DPR) is presently 64.91%.

A number of equities research analysts have issued reports on CLX shares. Jefferies Group reiterated a “hold” rating on shares of Clorox in a research report on Wednesday, August 3rd. B. Riley reiterated a “neutral” rating and issued a $109.00 target price on shares of Clorox in a research report on Tuesday, August 9th. Atlantic Securities assumed coverage on shares of Clorox in a research report on Tuesday, June 14th. They issued a “neutral” rating and a $138.00 target price for the company. Deutsche Bank AG restated a “hold” rating and set a $134.00 price target (up previously from $130.00) on shares of Clorox in a report on Sunday, July 24th. Finally, Zacks Investment Research downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Tuesday, July 5th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $128.90.

In related news, EVP Laura Stein sold 38,882 shares of the stock in a transaction on Friday, September 2nd. The shares were sold at an average price of $131.69, for a total transaction of $5,120,370.58. Following the completion of the transaction, the executive vice president now owns 48,501 shares in the company, valued at $6,387,096.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Nikolaos A. Vlahos sold 925 shares of the stock in a transaction on Wednesday, August 10th. The stock was sold at an average price of $133.07, for a total transaction of $123,089.75. The disclosure for this sale can be found here. 2.09% of the stock is currently owned by insiders.

About Clorox

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

5 Day Chart for NYSE:CLX

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co. (NYSE:CLX).

Receive News & Ratings for Clorox Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Co. and related companies with MarketBeat.com's FREE daily email newsletter.